Sunday, 22 November 2026

diarioempresas

IBEX 3518.873,10▼ -1,63%EuroStoxx 505941,95▼ -2,81%S&P 5006910,39▼ -3,70%€/$1,0975▲ +0,02%Brent89,95▲ +0,57%Bitcoin55.446▲ +1,20%
Breaking

Legit.Health achieves European certification for its skin diagnostic AI

A Bilbao startup receives MDR certification for its AI, identifying over 300 skin conditions from a photo and already working with two health services.

Marta Uriarte Elizondo
Marta Uriarte Elizondo
· 2 min read

A Bilbao startup has obtained European certification for its artificial intelligence system, which helps doctors identify over 300 skin conditions from an image. Dermatology consultations in Spain have an average wait of 127 days.

Dermatology consultations in Spain have an average wait of 127 days, more than four months, according to figures from the Ministry of Health. It is the second specialty with the longest delay, only behind traumatology, and exceeds the 102 days average of other specialties.

In light of this problem, the Bilbao startup Legit.Health has developed an artificial intelligence system, and the news of its certification has been reported by espaciodiario.com. The company has become the first to offer a healthcare product certified under the European Medical Device Regulation (MDR) to support the diagnosis of skin conditions and assess their severity.

From a single image, the system helps the doctor identify over 300 pathologies, from acne to melanoma. The certification indicates that the technology is ready to be integrated into clinical practice and comply with European health regulations.

I have also been one of those patients waiting months for an answer. That's why we created Legit.Health: so that the first doctor you see can find it sooner. Having the European regulation backing it is a guarantee for doctors and patients.

This is stated by Andy Aguilar, CEO and co-founder of the company.

The use is straightforward. The doctor photographs the lesion, and the system returns an ordered list of possible diagnoses, along with an objective assessment of the severity that allows tracking the patient's response to treatment. The tool helps decide which cases to refer to a specialist and with what urgency. The final decision always rests with the healthcare professional.

The startup, founded in Bilbao by experts in artificial intelligence, dermatology, and patients, also obtained in 2026 the certification from the National Security Scheme, an essential requirement to operate in the Spanish public health system. It collaborates with the Health Service of the Principality of Asturias and the Aragon Health Service, as well as with insurers IMQ and LUX MED, part of the Bupa group.

According to the company, the goal is for cases requiring quick attention, such as a possible cancerous skin lesion, to be addressed before other consultations.

Marta Uriarte Elizondo

Written by

Marta Uriarte Elizondo

Redactora

Graduada en ADE por la Autónoma y emprendedora frustrada (dos veces). Coleccionista de pitch decks, cafetera y optimista pese a las estadísticas; en Diario Empresas firma las pymes y las startups.